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ABSTRACT
In preterm infants, poor postnatal growth is associated with adverse neurocognitive
outcomes; conversely, rapid postnatal growth is supposedly harmful for future
development of metabolic diseases.
Conclusion: In this systematic review, observational studies reported consistent positive
associations between postnatal weight or head growth and neurocognitive outcomes;
however, there was limited evidence from the few intervention studies. Evidence linking
postnatal weight gain to later adiposity and other cardiovascular disease risk factors in
preterm infants was also limited.
INTRODUCTION
Developmental plasticity refers to the capacity of an
organism to adjust its phenotypic development in
response to environmental cues to maximise its reproduc-
tive fitness, possibly through epigenetic, metabolic and/or
anatomical mechanisms (1). Mismatch arises when the
predicted conditions do not correspond to the actual
environment and this can adversely impact long-term
health and longevity. Initial evidence that early exposure
to environmental cues can alter the risk of developing
metabolic diseases in humans came from associations
between low birthweight and higher incidence of coronary
heart disease or glucose intolerance (2). Low birthweight
can result from intrauterine growth restriction and/or
prematurity and, when followed by adequate postnatal
nutrition, rapid (‘catch-up’) growth typically occurs during
infancy. While this confers potential advantages for
preterm infants in terms of short-term survival and later
cognitive outcome, rapid catch-up growth may increase
the risk of metabolic disease later in life. The relative
importance of prenatal undernutrition versus postnatal
rapid growth to these outcomes is still unresolved. In
contemporary birth cohorts, postnatal rapid growth
occurs more often in infants who were subjected to
intrauterine growth restriction, but also reflects the
infant’s genetic potential, and can be induced in the
general population by excessive infancy nutrition, includ-
ing higher protein intake. Human growth is regulated by
Key Notes
 We aimed to identify sensitive periods of postnatal
growth in preterm infants associated with neurodevel-
opmental and metabolic outcomes.
 The dissonance between findings of intervention and
observational studies raises the possibility of confound-
ing by diseases or other factors that affect both growth
and cognition.
 Future nutritional intervention studies in preterm and
term infants should report effects on weight gain and
growth, as well as later body composition and neu-
rocognitive outcomes.
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genetic, epigenetic, nutritional and endocrine signals
orchestrated in a timely fashion, and each of these
mechanisms may be involved in long-term metabolic
programming (3).
There is a wealth of supportive evidence for develop-
mental programming from experimental animal models.
These have demonstrated causal effects of nutritionally
induced accelerated growth, with or without low birth-
weight, on long-term risks of metabolic dysfunction. Initial
studies in rats over 50 years ago demonstrated the detri-
mental effects of excess nutrition during lactation by
manipulation of litter size (4). Rats that were reared in
small litters where there was little competition for the
mother’s milk gained more weight during lactation and
remained fatter and heavier throughout life, even when
weaned onto a healthy low-fat diet, compared with animals
reared in larger litters. Strikingly, raising rodent pups in
large litters to reduce the plane of nutrition during lactation
protects genetically prone animals from becoming obese
(5). Manipulation of nutritional content during lactation
has similar effects (6). When mouse or rat offspring of
normally nourished mothers are suckled by dams fed a low-
protein diet, pups grow slowly and remain permanently
smaller and leaner than controls. Furthermore, these ani-
mals exposed to maternal low-protein diet during lactation
are resistant to diet-induced obesity. These findings
highlight the importance of nutrition during lactation in
determining long-term risk of obesity. Studies in rodent
models have also shown the association between low
birthweight followed by postnatal catch-up growth and
increased risks of obesity, cardiovascular disease, insulin
resistance and glucose intolerance. This has been demon-
strated in a range of different models where foetal growth
has been restricted including those employing maternal
caloric restriction, maternal protein restriction and
intrauterine artery ligation (6). Mice that were growth
restricted in utero by maternal protein restriction and that
then underwent accelerated growth through suckling a
normally fed dam are more susceptible to diet-induced
obesity. The mechanisms underlying these programming
effects remain to be fully established but may involve
permanent structural changes, epigenetic changes and
accelerated cellular ageing (6).
It has been suggested that avoidance of excessive rates of
early growth could have a role in the prevention of cardio-
vascular disease (7); however, the benefits and risks of this
approach must be carefully weighed in high-risk low birth-
weight groups. Preterm infants are considered to be partic-
ularly susceptible to developmental programming of adverse
health outcomes because of their abnormal ex-utero growth
patterns; the majority exhibit poor growth and weight gain
during the initial postnatal period between preterm birth to
full-term gestational age but subsequently most show spon-
taneous rapid catch-up growth back to their genetic trajec-
tory. Some studies suggest that in preterm infants, poor early
growth is associated with adverse neurodevelopmental
outcomes; thus, current nutritional strategies aim to enhance
their nutrient intake to promote rapid growth and brain
development despite the potential long-termmetabolic costs
(8). The objective of the present reviewwas to summarise the
available evidence on postnatal growth in preterm infants in
relation to the potential neurodevelopmental benefits and
adverse metabolic outcomes and attempt to identify critical
postnatal windows during which growth might influence
these outcomes.
METHODS
We extracted reports published before 2003 from the review
by Baird et al. (9). That extensive review included literature
on term infants (AGA+SGA) and a number of outcomes not
relevant to our review here (i.e. mental health, sudden
infant death), so only references that referred to i) preterm
infants, ii) early growth (rather than size during infancy)
and iii) developmental or metabolic outcomes that were
predefined were extracted for the current review. Seven
relevant papers were identified, all reported neurocognitive
or developmental outcomes, and these are marked in
Table 1a,b.
We performed a systematic search of electronic databases
(Medline (PubMed), EMBASE and Google Scholar) to
identify studies published between 2003 and May 2013
reporting associations between postnatal growth and later
neurocognitive or metabolic outcomes in preterm infants.
MeSH terms and search words representing the following
categories were combined: i) the population (e.g. preterm
infants), ii) postnatal growth (e.g. early weight gain; failure
to thrive) and iii) outcome related to neurocognitive
development (e.g. IQ; neurological impairment) or to
metabolic disease (e.g. percentage body fat). One investiga-
tor (KK) carried out the search and hand-searched the
reference lists of identified papers for further relevant
papers. Abstracts were read, and if thought to be relevant,
the full report was read and relevant data were extracted;
120 full papers published in 2003 or later were reviewed in
this way (Fig. 1).
Inclusion criteria:
Population
Definitions that were considered for this search were as
follows: ‘preterm infants; premature infants; premmie
births; low-birthweight infants; very low-birthweight
infants; extremely low birthweights; and preterm/prema-
ture SGA/IUGR infants’. Studies of populations that also
included term infants were included if the findings for the
preterm infants were presented separately.
Exposure
A measure of postnatal growth velocity that could be
compared between groups was identified. Care was taken
to use a definition that considered gains in weight and/or
head circumference between at least two time points (e.g.
between birth to age six weeks) rather than only measure-
ments of body size at one specific age. Growth was accepted
if reported as an absolute velocity or as a change in SD
scores; in the case of the latter, we required the growth
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reference used to be reported. Papers were accepted if the
outcome (see below) was assessed at the same age as the
second growth measurement, or later.
Outcomes
Neurocognitive development. Measures related to neu-
rocognitive outcomes included: ‘neurodevelopment;
intelligence; IQ; behaviour; motor and neurological impair-
ment’. We applied no limit regarding the age at outcome
assessment; the earliest was at the age of 12 months and the
oldest was in young adults (21 years).
Metabolic. Outcomes were included related to body
composition (e.g. overweight and obesity; percentage fat),
insulin resistance, glucose control or cardiovascular risk
factors (e.g. lipid profile; blood pressure).
Study design
Both intervention and observational studies were accepted.
We considered as ‘intervention studies’ those where the
intervention had an influence on postnatal growth and the
study also assessed one of our review outcomes above.
Some papers reported cohort analyses of interventional
studies (particularly where the intervention did not influ-
ence early growth); these were labelled as ‘observational’
evidence.
Exclusion criteria
We excluded animal studies and also studies where body
size at only one time point was reported. Queries about the
eligibility of specific studies were resolved by discussions
with MF and KO, or with all authors in cases of uncertainty.
Further studies suggested by co-authors for possible inclu-
sion were considered, but no new eligible studies were
identified in this way.
Data extraction and interpretation
KK was responsible for the data extraction, tabulation and
preliminary interpretation. Only published data were con-
sidered, and no further data were sought from authors.
Forty-nine individual reports were used (34 examining early
growth and later developmental outcomes and 15 examin-
ing metabolic outcomes); however, 20 (41%) of these
papers were used more than once, as they reported more
than one outcome of interest.
For each identified study, KK extracted information on
the following: study design, timing and nature of the
exposure, number of participants, and age at follow-up
measurements. All authors agreed on the generation of a
summary result indicator attributed to each study to show
whether it reported a positive effect/association between
postnatal growth and the outcome measure (‘++’ statisti-
cally significant positive association; ‘+’ nonsignificant
positive trend; ‘0’ no association; ‘-’ nonsignificant inverse
trend; and ‘—’ significant inverse association). Due to wide
heterogeneity between studies in the measurement and/or
categorisation of the exposure and outcome variables,
quantitative summary by meta-analysis was deemed not
possible.
RESULTS
Neurocognitive outcomes
Neurocognitive outcomes were assessed in six clinical
trials that promoted faster postnatal growth using a
nutritional intervention (Table 1a; Fig. 2) (10–15). Of
these, only one trial reported an overall benefit on
neurodevelopment, but only at the age of three months
and not at the age of 12 months (10) and one trial reported
a benefit only in subgroups of boys, but not in girls at the
age of 7–8 year (15). Both of these trials, and a third trial
that showed no benefit at 18 months (14), tested interven-
tions given during the prehospital discharge age period.
The other three trials tested posthospital discharge inter-
ventions: one promoted faster gains in weight, length and
HC in boys (11); and two promoted faster gains in weight
and length, but not HC (12,13); however, none had any
benefit for neurodevelopment, assessed at the age of
18 months in all three trials.
In observational studies, weight gain (n = 19 studies)
showed generally consistent positive associations with
neurocognitive outcomes at ages ranging from 12 months
to 19 year old (Table 1a; Fig. 2) (16–34). Outcomes were
measured using a variety of assessment tools across differ-
ent studies, largely reflecting the relevance of each tool to
specific age ranges. The timing of the postnatal weight gain
tested as the exposure also varied widely between studies,
from as early as birth-to-full-term age or hospital discharge,
to weight gain up to mid-childhood. No obvious period(s)
of postnatal weight gain was more consistently associated
with later neurocognitive outcomes. Whilst some of these
studies included adjustment for potential neonatal or
social confounders, only three included adjustment for
maternal IQ.
Potentially relevant papers 
Identified (PubMed) 
(n = 120) 
Excluded on the basis of the a review of 
abstract and/or complete paper (n = 79) 
Included articles 
(n = 41) 
Articles found through other sources 
(n =  8), including review of Baird et al. (9),  
suggestions from group members. 
Total articles included 
(n = 49) 
Figure 1 Flow chart for systematic review of literature on the effects of
postnatal growth in preterm infants and later health outcomes.
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Similarly, 16 observational studies reported on the
association between postnatal head growth and neurocog-
nitive outcomes (Table 1b; Fig. 3) (16,22,28–30,32,33,35–
43). Postnatal head growth showed generally consistent
positive associations with neurocognitive outcomes mea-
sured at ages ranging from 12 months old to adulthood,
although the benefits for neurodevelopment outcomes were
more consistent than for cognition. As for postnatal weight
gain, no obvious period(s) of postnatal head growth was
more consistently associated with later neurocognitive
outcomes.
Percentage body fat
Percentage body fat was assessed as an outcome in three
clinical trials that altered postnatal growth using a nutri-
tional intervention (Table 2a; Fig. S1) (12,44,45). In all
three trials, percentage body fat was assessed at the age of
12 months by DXA scans. In two trials (12,45), the
posthospital discharge intervention promoted faster weight
gain, but neither had any effect on percentage body fat. In
the third trial (44), surprisingly the enriched formula milk
intervention given from full enteral feeding to age
12 months led to lower weight gain (the authors suggested
this was due to lower milk intake, although this was not
measured) and also lower percentage body fat, consistent
with a positive relationship between weight gain and
adiposity.
Four observational studies reported on the association
between postnatal weight gain and percentage body fat
(Table 2a; Fig. S1) (46–49). The two larger studies reported
positive associations with percentage body fat in young
adults (48,49); both studies reported stronger effects of
weight gain during earlier (between birth to three months
corrected age) versus later infancy (between 3–12 months).
The two smaller studies reported no or variable associations
between postnatal weight gain and percentage body fat at
the ages of two year and 14 year (46,47).
Insulin resistance
Insulin resistance was assessed in only one clinical trial that
promoted faster postnatal growth using a nutritional inter-
vention (Table 2b; Fig. S2) (50). The nutrient-enhanced
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preterm formula milk given in the first four weeks of
postnatal life increased postnatal weight gain and also
increased fasting 32–33 split proinsulin levels at the age of
15 year, independent of BMI, although levels were similar
to those in healthy term-born individuals.
Of the four observational studies (49,51–53), three
reported positive associations between postnatal weight
gain and insulin resistance at the ages of 10 to 22 year
(Table 2b; Fig. S2) (51–53). However, there were inconsis-
tent findings between studies, including the timing of weight
gain related to insulin resistance [e.g. birth to three month
post-term (52); from 18 months only (51)], and whether
associations were only seen in subgroups [within preterm-
SGA but not preterm-AGA infants (53)]. Furthermore, only
one observational study showed that the association with
insulin resistance was independent of body composition
(53).
Other cardiovascular risk factors
Associations between postnatal weight gain and various
later CVD risk factors were reported by eight observational
studies; most had sample sizes >160 and had long follow-
up, to ages ranging from six to 21 year old (Table 2c;
Fig. S3) (33,47,49,54–58). Positive associations were vari-
ably and/or sparsely reported with arterial blood pressure
(two of five studies); total cholesterol levels (one of three
studies); flow mediated dilatation (one study); and carotid
artery intima-media thickness (one of one study). Further-
more, most of the studies that reported positive associations
did not include adjustment for body size at the time of
outcome assessment.
DISCUSSION
This systematic review of growth in preterm infants in
relation to later outcomes found only a few intervention
studies and a greater number of observational studies with
information on later neurocognitive, adiposity and insulin
resistance/cardiovascular risk factor outcomes. In relation
to neurocognitive outcomes, intervention studies that
aimed to promote postnatal growth in preterm infants,
whether during hospital stay or postdischarge, produced
little consistent evidence for beneficial effects of faster early
growth. The observational studies reviewed showed gener-
ally consistent positive associations between postnatal
weight gain and head growth (n = 18 and 15 studies,
respectively) and neurocognitive outcomes at ages ranging
from one year to adulthood, with no obvious period(s) of
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© 2015 ILSI Europe. Acta Pædiatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Pædiatrica 2015 104, pp. 974–986 981
Ong et al. Postnatal growth in preterm infants and later health
weight gain or head growth more consistently associated
with later outcomes. The dissonance between findings of
intervention and observational studies raises the possibility
of confounding in the latter by other factors, such as
neonatal morbidities that could directly affect both growth
and neurocognitive outcomes, although the paucity of
intervention studies limits conclusions.
In relation to later adiposity, our review of intervention
studies to promote postnatal growth in preterm infants
found no studies that assessed adiposity at ages older than
one year; of three trials, two promoted weight gain without
increasing percentage body fat, while in the third, the
enriched formula milk intervention led to lower weight
gain, perhaps as a result of lower milk intake. Among
Table 2 Postnatal weight gain in preterm born infants related to a) adiposity (% body fat); b) insulin resistance; c) other cardiovascular markers. Reports are ordered by study
design and age at outcome assessment
Design Timing of exposure (nature) N
Age at
outcome
Summary
result Comments
(a)Adiposity
Koo (44) int 41 day -12 months
(Enriched formula)
89 12 months ++ Intervention group surprisingly grew slower and had
lower %BF
Aimone (12) int discharge-3 months (HMF) 39 12 months 0 Intervention increased WT and length gains, but not %BF
Cooke (45) int discharge-6 months
(Preterm formula)
129 12 months + Intervention increased WT gain and both fat and lean mass;
nonsignificant increase in %BF
Hernandez (46) obs (b-2 weeks) b-4 weeks
(WT gain)
26 24 months (–) ++ Surprisingly, the effect of WT gain between b-2 weeks was
opposite to that for WT gain b-4 week
Ludwig-Auser (47) obs b-14 days (Energy intake) 61 14.5 years 0 Infants with intakes >70 vs. < 70 kcal/kg/days were taller
and heavier at the age of 14 years
Euser (48) obs b-3 months, 3–12 months
(WT gain)
403 19 years ++ Stronger effect of early vs. later WT gain on BMI & %FM.
Findings persisted when adjusted for height
Kerkhof (49) obs b-term, term-3 months
(WT gain, adj. length)
162 21 years ++ Compared rapid (>0.67 SD) vs. slow (<0.67 SD) catch-up
infancy WT gain. Stronger effect of early vs. later catch-up
(b)Insulin resistance
Singhal (50) int b-4 weeks (Preterm
formula)
216 15 years ++ Higher nutrient diet increased fasting 32-33 proinsulin
levels at 13–16 years (adjusted for BMI)
Fewtrell (51) obs b-18 months, 18
months-9 to 12
years (WT gain)
385 10 years ++ (18
months -9
to 12
year only)
WT gain 18 months -9/12 years associated with higher
fasting, split, proinsulin and 30 minutes insulin (adjusted
for HT & WT)
Finken (52) obs b-3 months (WT gain) 346 19 years ++ WT gain b-3 months associated with higher fasting insulin
resistance
Kerkhof (49) obs b-term, term-3 months
(WT gain, adj. length)
162 21 years 0 Insulin sensitivity was not associated with WT gain during
any period between b-12 months
Hovi (53) obs b-term (WT gain) 100 22 years ++ (only
in SGA,
not AGA)
WT gain b-term associated with higher fasting and 2 hour
insulin levels; only in SGA subgroup (n = 31) (adjusted
for BMI)
(c)CVD risk factors
Bracewell (54) obs b-term, term-30 months,
term-6 years (WT gain)
241 6 years 0 (BP) WT gain in any period was unrelated to BP at 6 year
(adjusted for BMI)
Belfort (33) obs term-12 months
(WT gain)
666 6 years ++ (BP) WT gain term-12 months associated with modestly higher
BP (in adjusted model, SBP was 0.7 mm Hg higher vs.
slower growing infants).
Ludwig-Auser
(47)
obs b-14 days (Energy intake) 61 14 years 0 (BP) Infants with intakes >70 vs. < 70 kcal/kg/day were taller
and heavier at the age of 14 years
Keijzer-Veen (55) obs b-5 years (WT gain) 588 19 years ++ (BP) Also positive association with childhood height growth
Mortaz (57) obs b-discharge; 18 months
(WT gain)
412 11 years 0 (Lipids) WT gain to 18 months was unrelated to various cholesterol
metabolism parameters (adjusted for current size)
Kerkhof (49) obs term-3 months, 9–12
months (WT gain)
162 21 years ++ (Lipids) –
(BP)
WT gain term-3 months –> higher TChol & LDL. WT gain
9-12 months –> higher TChol, LDL & ApoB. No
associations with BP
Singhal (58) obs b-4 weeks (WT gain) 216 15 years ++ (FMD) FMD was 4% lower in adolescents with high vs. low WT
gain (adjusted for HT & WT)
Finken (56) obs 3–12 months (WT gain) 346 19 years ++ (CIMT) –
(Lipids)
WT gain 3-12 months –> greater CIMT (but not when
adjusted for height). No associations with lipid profile
‘++’ statistically significant positive association; ‘+’ nonsignificant positive trend; ‘0’ no association; ‘-’ nonsignificant inverse trend; ‘–’ significant inverse association.
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observational studies with data on later adiposity, the two
larger studies found that greater weight gain from birth to
three months corrected age was associated with a higher
percentage body fat in young adulthood, with a weaker
effect of weight gain from age 3–12 months; smaller studies
reported no or variable associations between postnatal
weight gain and percentage body fat at the ages of two year
and 14 year. For insulin resistance, one intervention study
that promoted faster postnatal growth led to normalised
fasting 32–33 split proinsulin levels at the age of 15 year
relative to children born at term, whereas those who grew
more slowly in hospital had reduced proinsulin levels in
adolescence. Findings were inconsistent among the four
observational studies and only one reported an association
between faster growth and later insulin resistance indepen-
dent of body composition. No study in preterm infants
examined relations between nutritional intervention to
promote growth and other cardiovascular risk factors.
While observational studies variably reported some positive
associations between faster early growth and arterial blood
pressure, total cholesterol levels, flow mediated dilatation
and carotid intima-media thickness, most did not include
adjustment for body size at the time of outcome assessment.
An important limitation of this review was the inability to
perform quantitative summaries and to consider effect sizes
arising from the paucity of studies, the variability in which
these were reported and the inconsistency of adjustment for
generally agreed potentially confounding influences, most
notably current body size. A further limitation is that the
data available did not allow us to consider growth condi-
tional on the infant’s size at birth; this is important as a
previous systematic review found that larger size at birth is
associated with a higher risk of later obesity (59), and
postnatal growth patterns differ in small and large infants
(60). Potential sources of bias widely prevalent in the
studies considered included: insufficient description of
participants, high attrition rates in both the intervention
and observational studies, and inadequate consideration of
confounding factors. Publication bias may be a further
source of error and was not formally analysed in our review
due to the absence of quantitative summaries.
It is important to recognise that these findings in preterm
infants may not be applicable to term-SGA infants; focused
studies in this group are needed to determine whether
developmental adaptations induced before birth in term-
SGA infants result in their responses to nutritional inter-
ventions to promote growth being different to those of
preterm infants. In this respect, a previous systematic
review concluded that term infants who grow rapidly
during infancy are at increased risk of subsequent obesity,
but did not consider neurocognitive outcomes (59).
Prematurity has a high and increasing prevalence world-
wide. It is widely recognised that the growth of preterm
infants is frequently suboptimal, with many being dis-
charged at lower percentiles for weight, head circumference
and length than those at which they were born (61).
Moreover, preterm infants are particularly susceptible to
developmental programming of adverse neurodevelopmen-
tal, body composition and metabolic outcomes. Despite
some evidence that the prevalence of childhood overweight
and obesity is no longer rising in a number of populations
the prevalence remains at an unacceptably high level. This
high prevalence has major implications for the global
burden of ill health and disease and preterm infants are
an important group in which to optimise early nutrition and
later outcomes. Having common outcome measures for
infant nutrition trials in both preterm and term infants
would lead to a strengthened evidence base for nutritional
interventions to improve growth and long-term outcomes
during this important period of development. A recent
systematic review found that early parenteral nutrition in
preterm infants improves short-term growth outcomes (62).
Among very preterm infants nutrition is often suboptimal
(63), and while there is yet no evidence linking progressive
advancement of enteral milk feeds to risk of adverse short-
term outcomes, such as necrotising enterocolitis and late-
onset infection, the need for further trials is recognised (64).
In summary, only a few predischarge intervention studies
to promote growth in preterm infants have information on
later neurocognitive, adiposity and insulin resistance/car-
diovascular risk factor outcomes. While there is abundant
and consistent evidence from observational studies linking
faster postnatal growth to better neurocognitive outcomes
in preterm infants, these studies show no obvious windows
of association and there is a high risk of confounding by
other factors/disease processes that affect both growth and
cognition. Where associations are reported in observational
studies linking faster postnatal growth to adverse cardio-
vascular risk markers in preterm infants, the findings have
often not been adjusted for body size at the time of the
outcome measurements. Moreover, comparisons were often
not made to the normal ranges of these outcome parameters
in unselected populations. Further research is needed to
determine the optimal growth in preterm infants to achieve
neurocognitive benefits while minimising the longer-term
risk of chronic disease. We therefore strongly support the
recommendation of the COMMENT initiative (65) that all
nutritional intervention studies in preterm and term infants
should report effects on weight gain and growth, as well as
later body composition and neurocognitive outcomes.
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